Sai Parenteral’s IPO Listing Preview: What to Expect Now?

Mon Mar 30 2026

The Sai Parenteral’s Limited listing is scheduled for 2nd April 2026. The IPO was opened for bidding from 24th March 2026 to 27th March 2026. It is a bookbuilding IPO of ₹408.00 crores, entirely a fresh issue of 0.73 crore shares. The issue will be listed on NSE and BSE on its tentative listing date, 2nd April 2026. Scroll down to know more about Sai Parenteral’s IPO listing expectations.

Table of Contents

Sai Parenteral’s IPO Listing Preview

According to recent updates, the IPO listing of Sai Parenteral’s could be around ₹392 per share on 2nd April 2026. This conclusion is based on Sai Parenteral’s GMP (grey-market premium). However, the GMP and expected listing price are subject to change based on market sentiment. Stay informed with Univest to get live updates on the Complex Cinemas IPO listing or GMP trends. Scroll to explore the GMP of the Sai Parenteral’s IPO.

Sai Parenteral’s IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Sai Parenteral’s IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

GMP DATE	IPO Price	GMP Price	Estimated Listing Price	Estimated Gain
31-3-2026	₹392.00	₹0.00	₹392.00	0.00%
30-3-2026	₹392.00	₹0.00	₹392.00	0.00%
29-3-2026	₹392.00	₹0.00	₹392.00	0.00%
28-3-2026	₹392.00	₹0.00	₹392.00	0.00%
27-3-2026	₹392.00	₹0.00	₹392.00	0.00%
26-3-2026	₹392.00	₹0.00	₹392.00	0.00%
25-3-2026	₹392.00	₹0.00	₹392.00	0.00%
24–3-2026	₹392.00	₹0.00	₹392.00	0.00%
23-3-2026	₹392.00	₹0.00	₹392.00	0.00%
22-3-2026	₹392.00	₹0.00	₹392.00	0.00%
21-3-2026	₹392.00	₹0.00	₹392.00	0.00%
20-3-2026	₹392.00	₹0.00	₹392.00	0.00%
19-3-2026	₹392.00	₹0.00	₹392.00	0.00%
18-3-2026	₹392.00	₹0.00	₹392.00	0.00%

As of 30th March 2026, the Sai Parenteral’s IPO GMP stands at ₹0 per share. This means shares are likely to list at ₹392.00 on their tentative listing date, 2nd April 2026. GMP data is subject to change based on market conditions. You should check the live GMP status before applying for the Sai Parenteral’s IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends.

Sai Parenteral’s Limited Financials

The company’s financial analysis is essential before applying for Sai Parenteral’s IPO. See the table for Sai Parenteral’s Limited’s financials.

Year Ended	31st Dec 2025 (in cr.)	31st March 2025 (in cr.)	31st March 2024 (in cr.)	31st March 2023
Assets	376.24	272.39	268.10	133.96
Total Income	89.43	163.74	155.18	97.03
Profit After Tax	7.76	14.43	8.42	4.38
EBITDA	16.24	39.44	31.70	17.64
Net Worth	209.37	95.78	76.40	31.49
Reserves and Surplus	188.84	80.36	61.30	24.34
Total Borrowings	76.07	93.95	118.79	68.35

Explanation

Sai Parenteral’s Limited’s revenue increased by 5%, from ₹10.99 crore in March 2024 to ₹14.17 crore in March 2025. Moreover, the company’s PAT increased by 4% from ₹2.39 crore in March 2024 to ₹2.52 crore in March 2025.

How to Check the Sai Parenteral’s IPO Allotment Status?

You can check for the Sai Parenteral’s IPO allotment in different ways. These include NSE and the registrar portal. Follow the steps below to check your allotment status online.